With 0.88 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.66 million shares. During the session, the Insurance – Life company that operates in wider Financial sector, reached to the highest price of $93.565 whereas the lowest price it dropped to was $88.305. The 52-week range on JXN shows that it touched its highest point at $115.22 and its lowest point at $64.70 during that stretch. It currently has a 1-year price target of $99.00. With its current market cap of 6.19 billion, JXN has annualized dividend of $3.00 while the current yield stands at 3.37%. JXN paid its most recent dividend on 1749686400, while the ex-dividend date for that was 1757894400. Beta for the stock currently stands at 1.46.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of JXN was up-trending over the past week, with a rise of 1.55%, but this was up by 3.72% over a month. Three-month performance surged to 7.04% while six-month performance fell -3.20%. The stock gained 2.11% in the past year, while it has gained 28.68% so far this year. A look at the trailing 12-month EPS for JXN yields -0.06 with Next year EPS estimates of 22.23. For the next quarter, that number is 5.20. This implies an EPS growth rate of 7.94% for this year and 9.59% for next year.
Float and Shares Shorts:
At present, 69.96 million JXN shares are outstanding with a float of 68.02 million shares on hand for trading. On 2025-07-15, short shares totaled 2.92 million, which was 409.00003 higher than short shares on 1749772800. In addition to Ms. Laura Louene Prieskorn as the firm’s CEO, President & Director, Mr. Don Wayne Cummings serves as its Executive VP, CFO, Controller & Chief Accounting Officer.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for JXN since 2 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With JXN analysts setting a high price target of 118.0 and a low target of 88.0, the average target price over the next 12 months is 99.0. Based on these targets, JXN could surge 32.7% to reach the target high and fall by -1.03% to reach the target low. Reaching the average price target will result in a growth of 11.34% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $19.44049 being high and $18.59573 being low. For JXN, this leads to a yearly average estimate of $19.01811. The surprise factor in the prior quarter was $4.93. Based on analyst estimates, the high estimate for the next quarter is $5.35 and the low estimate is $5.35. The average estimate for the next quarter is thus $5.35.
